ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV
9 April 2009
Director/PDMR Shareholding
Reed Elsevier received notification today from the Trustees of the Reed Elsevier Employee Benefit Trust ('the Trustees'), that between 7-8 April 2009 the Trustees purchased on behalf of the Directors/PDMRs of Reed Elsevier the number of shares/ADRs noted in the table below, under the terms of the Reed Elsevier Group plc Bonus Investment Plan. As a consequence of these purchases, the Directors/PDMRs received matching awards over the number of shares/ADRs also noted in the table below.
Additionally, Reed Elsevier received notification today that on 7 April 2009, Mr Andrew Prozes, a director of Reed Elsevier sold 10,500 Reed Elsevier PLC ADRs and 14,000 Reed Elsevier NV ADRs at the respective price of $29.2112 and $21.6434 per ADR.
Following these transactions, the interests of the Directors in the share capital of Reed Elsevier PLC and Reed Elsevier NV is as noted below.
Director |
Reed Elsevier PLC ordinary shares purchased on behalf of the director |
Reed Elsevier |
Reed Elsevier PLC ordinary shares matching award |
Reed Elsevier |
Current interest in Reed Elsevier PLC ordinary shares |
Current interest in Reed Elsevier |
Mark Armour |
16,351 |
10,942 |
27,886 |
18,568 |
244,413 |
136,889 |
Erik Engstrom |
|
17,144* |
|
28,608* |
107,040 |
365,581 |
Andrew Prozes |
19,281 |
12,960 |
32,335 |
21,626 |
190,542 |
141,204 |
* Denotes purchase/award of an ADR. Each Reed Elsevier PLC ADR represents 4 Reed Elsevier PLC ordinary shares and each Reed Elsevier NV ADR represents 2 Reed Elsevier NV ordinary shares.
PDMR |
Reed Elsevier PLC ordinary shares purchased on behalf of the PDMR |
Reed Elsevier PLC ordinary shares matching award |
Ian Fraser |
21,294 |
36,316 |
The purchases by the Directors/PDMRs were at the following prices:
Reed Elsevier PLC ordinary shares 500.4559p per share
Reed Elsevier NV ordinary shares €8.252223 per share
Reed Elsevier NV ADRs $21.5871 per ADR
The Reed Elsevier Group plc Bonus Investment Plan permits directors and other senior executives to invest up to one half of their annual bonus in shares in the company, and receive an equivalent award of nil cost restricted shares from Reed Elsevier Group plc. The matching awards under the Plan vest after three years, subject to the participant retaining the shares which they have purchased under the Plan for a period of three years. Vesting of the above awards is subject to the achievement of 8% per annum compound growth in adjusted EPS at constant currencies over the 2009 - 2011 performance period.